Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable ...

Diagnosis Tophaceous gout associated with urate nephropathy in a patient intolerant to allopurinol. Management Acute polyarthritis was successfully managed by intravenous bolus methylprednisolone ...

and tolerability of serum uric acid lowering and maintenance with febuxostat in patients with gout. Febuxostat Open-label Clinical Trial of Urate-lowering Efficacy and Safety Adverse events were ...

CALGARY, Alberta, Jan. 29, 2025 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA) ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

OBJECTIVES To study the efficacy of allopurinol and benzbromarone to reduce serum urate concentrations in patients with primary chronic gout. METHODS Prospective, parallel, open study of 86 ...

Gout affects around one in 40 people in developed ... Current first-line therapies like allopurinol and febuxostat can be very effective, but some patients – roughly 1% according to FDA ...

Zurampic is approved by the FDA for hyperuricemia associated with uncontrolled gout, in combination with a xanthine oxidase inhibitor (XOI). Duzallo is a combination of lesinurad and allopurinol ...

Eligible for inclusion were adult patients (≥18 years) with microscopically verified gout who initiated or increased ULT (allopurinol, benzbromarone or febuxostat). For the latter group, crystal ...